36th EDRN Steering Committee Meeting - Tuesday 27 October Agenda
| 11:00 a.m. - 11:05 a.m. (all times Eastern Daylight Time) | Welcome and Opening of the October 2020 EDRN Steering Committee Meeting Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute |
| 11:05 a.m. - 11:15 a.m. EDT |
Opening Remarks Philip E. Castle, Ph.D., M.P.H., Director, Division of Cancer Prevention, National Cancer Institute 01-Charge to Participants Sudhir Srivastava, Ph.D., M.P.H., National Cancer Institute |
| 11:15 a.m. - 1:10 p.m. EDT |
Session 1 - What Target Sensitivity and Specificity Might Confer Clinical Utility? Moderators: Steve Skates, Ph.D., Massachusetts General Hospital/Harvard Robert Schoen, M.D., University of Pittsburgh Cancer Institute NCI Program Directors: Jacob Kagan, Ph.D., M.Sc. Lynn Sorbara, Ph.D. Note Takers: Steve Skates and Lynn Sorbara |
| 11:15 a.m. - 11:30 a.m. EDT |
02-Ovarian Cancer Steven Skates, Ph.D., Massachusetts General Hospital/Harvard |
| 11:30 a.m. - 11:35 a.m. EDT | Q&A |
| 11:35 a.m. - 11:50 a.m. EDT |
03-Prostate Cancer Martin Sanda, M.D., Emory University |
| 11:50 a.m. - 11:55 a.m. EDT | Q&A |
| 11:55 a.m. - 12:10 p.m. EDT |
04-Pancreatic Cancer Randall Brand, M.D., University of Pittsburgh |
| 12:10 p.m. - 12:15 p.m. EDT | Q&A |
| 12:15 p.m. - 12:30 p.m. EDT |
05-Colon Cancer Uri Ladabaum, M.D., Stanford University School of Medicine |
| 12:30 p.m. - 12:35 p.m. EDT | Q&A |
| 12:35 p.m. - 12:50 p.m. EDT |
06-Lung Cancer Harry de Koning, M.D., Ph.D., Erasmus University Medical Centre |
| 12:50 p.m. - 12:55 p.m. EDT | Q&A |
| 12:55 p.m. - 1:15 p.m. EDT | Further Discussion |
| 1:15 p.m. - 1:20 p.m. EDT | Break |
| 1:20 p.m. - 3:20 p.m. EDT |
Session 2 - Modeling, Biomarkers and Implementation Science Moderators: Ziding Feng, Ph.D., Fred Hutchinson Cancer Research Center Ruth Etzioni, Ph.D., Fred Hutchinson Cancer Research Center NCI Program Directors: Christos Patriotis, Ph.D. Matt Young, Ph.D. Note Takers: Ruth Etzioni and Christos Patriotis |
| 1:20 p.m. - 1:40 p.m. EDT | 07-Combining Biomarkers with Lung Cancer Low-Dose CT Screening - Assessing Potential Impact Via Simulation ModelingRafael Meza, Ph.D., University of Michigan |
| 1:40 p.m. - 1:45 p.m. EDT | Q&A |
| 1:45 p.m. - 2:05 p.m. EDT | 08-Asking the Right Questions: Modeling Risk Stratification and Novel Biomarkers for Prostate CancerRuth Etzioni, Ph.D., Fred Hutchinson Cancer Research Center |
| 2:05 p.m. - 2:10 p.m. EDT | Q&A |
| 2:10 p.m. - 2:30 p.m. EDT | 09-Elements of Prediction: CRC Screening, New Biomarkers, and Comparative EffectivenessCarolyn Rutter, Ph.D., RAND Corporation |
| 2:30 p.m. - 2:35 p.m. EDT | Q&A |
| 2:35 p.m. - 2:55 p.m. EDT | 10-Barriers to Effective Hepatocellular Carcinoma Surveillance and Potential Role of BiomarkersAmit Singal, M.D., The University of Texas Southwestern Medical Center |
| 2:55 p.m. - 3:00 p.m. EDT | Q&A |
| 3:00 p.m. - 3:20 p.m. EDT | Future Directions |
| 3:20 p.m. - 3:30 p.m. EDT | Break |
| 3:30 p.m. - 6:00 p.m. EDT |
Session 3 - Health Disparity and Biomarker Research Moderators: Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center Martin Sanda, M.D., Emory University Pierre Massion, M.D., Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center NCI Program Directors: Jo Ann Rinaudo, Ph.D. Sharmistha Ghosh-Janjigian, Ph.D. Note Takers: Christopher Li and Sharmistha Ghosh-Janjigian |
| 3:30 p.m. - 3:35 p.m. EDT | Introduction by Session Moderators |
| 3:35 p.m. - 3:45 p.m. EDT |
11-CRCHD Funding Opportunity for EDRN Investigators Anil Wali, Ph.D., Program Director, Center to Reduce Cancer Health Disparities (CRCHD), National Cancer Institute |
| 3:45 p.m. - 3:50 p.m. EDT | Q&A |
| 3:50 p.m. - 4:10 p.m. EDT |
12-Increasing Colorectal Cancer Screening and Follow-up through Partnerships with Community Health Centers Elena Martinez, Ph.D., Associate Director, Population Science, Disparities and Community Engagement, University of California, San Diego |
| 4:10 p.m. - 4:15 p.m. EDT | Q&A |
| 4:15 p.m. - 4:20 p.m. EDT | Break |
| 4:20 p.m. - 4:40 p.m. EDT |
13-Keynote Presentation: Prostate Cancer Detection and Health Disparities Otis Brawley, M.D., Bloomberg Distinguished Professor of Oncology and Epidemiology at the Sidney Kimmel Comprehensive Cancer Center, School of Medicine and Department of Epidemiology, Bloomberg School of Public Health of Johns Hopkins University |
| 4:40 p.m. - 4:45 p.m. EDT | Q&A |
| 4:45 p.m. - 5:05 p.m. EDT |
14-Lung Cancer Health Disparity and Screening Robert Winn, M.D., Director, Massey Cancer Center, Virginia Commonwealth University |
| 5:05 p.m. - 5:10 p.m. EDT | Q&A |
| 5:10 p.m. - 5:30 p.m. EDT |
15-Biological Determinants of Breast Cancer Disparities Melissa Davis, Ph.D., Assistant Professor, Weill Cornell Medicine |
| 5:30 p.m. - 5:35 p.m. EDT | Q&A |
| 5:35 p.m. - 6:00 p.m. EdT | Panel Discussion |
| 6:00 p.m. EDT | Adjourn for the Day |